Thirdly, data on other potential genetic modifiers closely associated with NAFLD, such as TM6SF2, HSD17B13, and MBOAT7, would have been valuable to have. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.